IDXX

IDEXX Laboratories, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-20

Figures on this page computed 2026-11-08 13:27 UTC

Last close

698.55USD

Market data, 2026-11-04

IDXX: weekly closes from 550.96 on 2026-08-14 to 698.55 on 2026-11-04, a move of +26.8%. Prices in USD.

Weekly closes, 2026-08-14 to 2026-11-04

Over that span: +26.8%

Except where said otherwise: 10-K for 2025, filed 2026-02-20

51.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-20
The filing itself
54.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself
24.6%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
24.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
0.36Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.09 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.46x

1.74x

1.97x

0.76x

1.76x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-20

Sales1.46x
Its own average over 10 years, 2.95B.
Profit1.74x
Its own average over 10 years, 608.8M.
Free cash flow1.97x
Its own average over 10 years, 537.1M.
Debt0.76x
Its own average over 10 years, 756.8M.
Price1.76x
Its own average over 11 years, 397. Market data, 2026-11-04

Free cash flow is furthest from its own average, at 1.97 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-12-31	100.0	100.0	100.0
2017-12-31	110.9	118.5	98.6
2018-12-31	124.7	169.8	97.3
2019-12-31	135.6	192.6	96.3
2020-12-31	152.5	262.0	95.4
2021-12-31	181.1	335.4	95.3
2022-12-31	189.7	305.8	93.1
2023-12-31	206.2	380.6	92.4
2024-12-31	219.5	399.9	91.6
2025-12-31	242.4	477.1	89.2

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0000874716-26-000038
Reported in: USD

The filing itself

How profit was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0000874716-26-000038
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0000874716-26-000038
Reported in: USD

The filing itself

Figures behind the shape

Growth

9.7%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate9.7%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth rate14.1%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income19.3%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

54.3%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital54.3%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself
Return on equity66.0%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself
Return on assets31.6%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself

Margins

61.8%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin61.8%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
Operating margin31.6%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
Net margin24.6%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
Free cash flow margin24.6%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself

Price

51.3x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings51.3x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-20
The filing itself
Price to book34.1x10-Q for 2025, filed 2026-11-02
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0000874716-26-000135
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-11-02
- computed
- 10-K for 2025, filed 2026-02-20
The filing itself
EV to EBITDA36.7x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
The filing itself
Price to sales ratio12.7x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself

Safety

0.36

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.36
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself
Current ratio1.2310-Q for 2025, filed 2026-11-02
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0000874716-26-000135
Reported in
USD
- 10-Q for 2025, filed 2026-11-02
- 10-Q for 2025, filed 2026-11-02
The filing itself
Interest coverage35.0x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
Altman Z-Score24.22
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- Computed from the 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.